Establishment Labs (ESTA)
(Real Time Quote from BATS)
$48.32 USD
+0.54 (1.13%)
Updated Jul 25, 2024 10:40 AM ET
4-Sell of 5 4
F Value D Growth C Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ESTA 48.32 +0.54(1.13%)
Will ESTA be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for ESTA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ESTA
Establishment Labs (ESTA) Surges 7.4%: Is This an Indication of Further Gains?
Establishment Labs Holdings Inc. (ESTA) Reports Q1 Loss, Tops Revenue Estimates
ESTA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Establishment Labs Holdings Inc. (ESTA) Reports Q4 Loss, Tops Revenue Estimates
Analysts Estimate Establishment Labs Holdings Inc. (ESTA) to Report a Decline in Earnings: What to Look Out for
Establishment Labs Holdings Inc. (ESTA) Reports Q3 Loss, Lags Revenue Estimates
Other News for ESTA
Establishment Labs to Announce Second Quarter 2024 Financial Results on August 6
Buy Rating Affirmed for ESTA Amid Market Recovery and Anticipated FDA Approval
Buy Rating on ESTA: Anticipating FDA Approval and Swift U.S. Market Penetration
Establishment Labs Holdings (ESTA) Gets a Buy from Jefferies
Establishment Labs price target raised by $5 at Mizuho, here's why